At the recently opened FENS Forum 2026 in Barcelona - the Federation of European Neuroscience Societies' flagship congress ...

Vera Therapeutics Inc. looks to get an almost five-month head start over a competitor, Vertex Pharmaceuticals Inc., as the U.S. FDA cleared its Trutakna (atacicept) as the first dual BAFF/APRIL ...

Despite the Biosecure Act’s five-year wind-down period that isn’t expected to start until mid-2028, Wuxi Apptec is already ...

Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Astex, Baiyunshan, Genentech, Incyte, Natera, Roche, Sanyou, Star, Tempramed, Vega.

Novartis AG is to pay $1.1 billion up front to acquire Myricx Bio Ltd., a preclinical-stage antibody-drug conjugate (ADC) ...

Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The ...

Mira Pharmaceuticals Inc. has reported results from preclinical studies evaluating an optimized oral formulation of SKNY-1, an oral drug candidate being developed for obesity and addiction-related ...

Biopharma and med-tech companies in Asia-Pacific raising money in public or private financings: Biobot Surgical.

Astrazeneca plc has returned to China’s CSPC Pharmaceutical Group Ltd. for another discovery collaboration, this time in a ...

As China becomes a major source of global clinical trial evidence, the retraction of a high-profile China-led lung cancer study is raising questions about whether journals, regulators and drug ...

Wigen Biomedicine Technology (Shanghai) Co. Ltd. has synthesized new phosphatidylinositol 3-kinase α (PI3Kα) modulators potentially useful for the treatment of solid tumors and hematological cancers.

Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev ...